Layoffs at Sangamo Therapeutics
- Layoff events
- 4
- verified and sourced
- Roles reported
- 426
- roles in total
- Announced between
- Apr 2023 to Jun 2026
- Reported by
- U.S. Securities and Exchange Commission and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Sangamo Therapeutics: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Sangamo Therapeutics |
Insolvency
Sangamo Therapeutics disclosed a restructuring eliminating approximately 51 U.S. roles while filing for Chapter 11 bankruptcy and pursuing asset sales. |
51 | Not known | United States |
2 sources for Sangamo Therapeutics |
|
| Sangamo Therapeutics |
Site closure
Sangamo Therapeutics announced the wind-down of its French research and manufacturing operations, eliminating all 93 positions in France. |
93 | Not known | French research and manufacturing operations, France |
1 source for Sangamo Therapeutics |
|
| Sangamo Therapeutics |
Restructuring
Sangamo Therapeutics announced 162 layoffs, about 40% of its U.S. workforce, and closure of its Brisbane headquarters. |
162 | Not known | Brisbane headquarters, Brisbane, United States |
1 source for Sangamo Therapeutics |
|
| Sangamo Therapeutics |
Restructuring
Sangamo Therapeutics announced a workforce reduction of around 120 employees, about 27% of its U.S. workforce, while refocusing its genomic-medicine portfolio. |
120 | Not known | United States |
1 source for Sangamo Therapeutics |
Where this comes from
Every cut listed for Sangamo Therapeutics was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Sangamo Therapeutics? Tell us on our Discord and we will check it.